Anti-osteoporotic treatment involves a range of medical interventions aimed at preventing or managing osteoporosis, a condition characterized by weakened bones and increased fracture risk. These treatments typically include calcium and vitamin D supplementation to support bone health, alongside medications such as bisphosphonates, selective estrogen receptor modulators (SERMs), parathyroid hormone analogs, and monoclonal antibodies like denosumab to reduce bone resorption or stimulate bone formation. Lifestyle modifications, including weight-bearing exercises, smoking cessation, and limiting alcohol intake, are also integral to the treatment plan. Early diagnosis and consistent treatment play a crucial role in preserving bone density, minimizing fracture risk, and improving the overall quality of life in individuals with or at risk of osteoporosis.
